Global Capnography Equipment Market OverviewThe global capnography equipment market is anticipated to grow at a steady pace with an estimated compound annual growth rate of around 5% over the next ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Novo Nordisk is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. The move escalates the ...

Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially “hundreds of millions” in damages, John Kuckelman, the pharma’s general counsel, said. The ...

The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss pill, including restricting access to the drug's ingredients ...

The Federal Reserve on Wednesday announced it will leave interest rates unchanged, breaking a streak of three straight rate cuts amid uncertainty over the labor market and inflation. Fed policymakers ...

CHICAGO, IL. The Los Angeles Rams barely escaped Chicago with a win but now that victory is secured and the Rams have punched their ticket to the NFC Championship, here's the good, bad, and ugly from ...

Forbes contributors publish independent expert analyses and insights. I show you how to save and invest. The Federal Open Market Committee is expected to move interest rates lower in 2026, but not ...

Jan 12 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of blockbuster GLP-1 drugs, ...